Kinex Pharmaceuticals to Present at 101st Annual Meeting of American Association for Cancer Research

BUFFALO, N.Y., April 14 /PRNewswire/ -- Kinex Pharmaceuticals (Buffalo, NY) is scheduled to make four presentations at the 101st Annual Meeting of the American Association for Cancer Research (AACR) that will take place at the Walter E. Washington Convention Center in Washington, DC on April 17-21, 2010. The theme of the meeting, "Conquering Cancer through Discovery Research" is expected to recruit more than 20,000 cancer researchers, health professionals, cancer survivors and advocates and will highlight novel approaches and technologies being used in the laboratory and in the clinic.

Pre-clinical data on KX2-361, a novel therapeutic for glioma, will be presented with collaborators from Roswell Park Cancer Institute, Drs. Robert Fenstermaker and Michael Ciesielski. This compound is a synthetic orally bioavailable small molecule with very high CNS penetration and proven efficacy in a mouse model of glioma. KX2-361 is well tolerated and approximately 60% of treated mice experience complete cures, as documented by MRI.

About Kinex Pharmaceuticals

For more information, visit www.kinexpharma.com

CONTACT: Lyn Dyster, +1-716-881-8984, for Kinex Pharmaceuticals

Web site: http://www.kinexpharma.com/